Bronchitis News and Research

RSS

Bronchitis is a condition in which the bronchial tubes, the tubes that carry air to your lungs, become inflamed. (For more information on the bronchial tubes and the airways. People who have bronchitis often have a cough that brings up mucus. Mucus is a slimy substance made by the lining of the bronchial tubes. Bronchitis also may cause wheezing (a whistling or squeaky sound when you breathe), chest pain or discomfort, a low fever, and shortness of breath. There are two main types of bronchitis: acute (short term) and chronic (ongoing).

Diesel exhaust kills throat cells

Researchers at Deakin University have found that diesel exhaust is far more damaging to our health than exhaust from biodiesel, the plant-based fuel.

12 Sep 2007

Link between nicotine and atherosclerosis

It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.

11 Sep 2007

GSK receives FDA 'not approvable letter' for Advair for COPD

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

9 Aug 2007

One joint as bad as five cigarettes

The latest research says the effects of a single cannabis 'joint' could damage the lungs as much as smoking up to five tobacco cigarettes one after another.

31 Jul 2007

Respiratory ailments are leading reasons for hospitalized children and teens

About 3 of every 10 children and teens who are admitted to the hospital from the emergency room have asthma, pneumonia, acute bronchitis or another respiratory disorder, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

16 Jul 2007

Some smokers have genetic predisposition to develop chronic obstructive pulmonary disease

Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease (COPD) if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.

12 Jul 2007

People with chronic obstructive pulmonary disease have greater arterial stiffness

The researchers also found that those COPD patients with osteoporosis, a common complication of the respiratory disease, had even greater arterial stiffness. These premature signs of aging may explain why COPD patients are at greater risk for cardiovascular disease.

19 Jun 2007

Children receiving antibiotics before age 1 at greater risk for asthma by age 7

The study, published in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), reports that children receiving antibiotics in the first year of life were at greater risk for developing asthma by age 7 than those not receiving antibiotics.

14 Jun 2007

Babies given antibiotics more likely to develop asthma

Canadian researchers are suggesting that children who receive antibiotics as infants have a greater risk of developing asthma by the age of 7, than those children not given antibiotics.

12 Jun 2007

Infant swimming lessons may not be such a good idea

Belgian researchers are suggesting that the chlorine in swimming pools may have an adverse effect on children's lungs.

5 Jun 2007

Seniors and heart disease: Lower cholesterol, cut your risk

A new report from RetireSafe's Senior Center for Health and Security examines how statins can be an effective treatment for lowering cholesterol and cutting the overall risk of heart disease in America's seniors. among Americans.

24 May 2007

Clinical trial data for Perforomist Inhalation solution

Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).

22 May 2007

Mediterranean diet halves risk of chronic obstructive pulmonary disease

A Mediterranean diet halves the chances of developing progressive inflammatory lung disease (COPD), reveals a large study, published ahead of print in Thorax.

16 May 2007

FDA approves Dey, L.P.'s NDA for chronic obstructive pulmonary disease inhalation solution

Dey, L.P. has announced that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

15 May 2007

Mediterranean diet found to halve the risk for lung disease

French researchers say eating a Mediterranean diet halves the risk of serious lung disease such as emphysema and bronchitis.

15 May 2007

Low frequency of resistance to Tamiflu confirmed

New data published by the World Health Organisation (WHO) has confirmed a low frequency of resistance to Tamiflu (oseltamivir) over 3 influenza seasons (2003:2006).

10 May 2007

Tens of thousands of Americans die each year from secondhand tobacco smoke

While the health risks associated with indoor secondhand smoke are well documented, little research has been done on exposure to toxic tobacco fumes outdoors.

4 May 2007

Infliximab fails to improve chronic obstructive pulmonary disease symptoms

A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multi-center trial.

2 May 2007

FDA advisory committee supports Advair 500/50 in reducing COPD exacerbations

An Advisory Committee to the Food and Drug Administration (FDA) has unanimously agreed that GlaxoSmithKline's Advair Diskus 500/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a significant reduction in the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the U.S.

2 May 2007

Doctors ill equipped to confront parent smoking

With the growing concerns of children's exposure to secondhand smoke, it has become more critical than ever to involve health care providers such as pediatricians in educating parents about the potential hazardous health consequences.

2 May 2007